[Is Widal syndrome always a severe disease?]

Pneumologia. 2006 Jul-Sep;55(3):105-8.
[Article in Romanian]

Abstract

Context: the Widal syndrome (WS) is known as the association of bronchial asthma to aspirin intolerance, nasal polyposis and/or allergic rhinitis, typical considered to have a difficult course.

Objectives: finding the prevalence and severity of WS in general medical practice. VENUE: data bases from a private pneumology practice and the ambulatory of a pneumology clinic in Timisoara.

Participants: 473 asthma patients, among which 41 (8.66%) matched the criteria for WS. There were 31 women (75.6%) and 10 men (24.39%). MAIN PARAMETERS EVALUATED: spirometry, ENT examination, skin allergy tests, serum IgE.

Results: most cases (22 pts., 53.65%) had mild to moderate asthma. Monitoring the cases for 4 years didn't show any worsening. The 19 severe cases (46.35%) had a progressive course, despite a complex treatment (anti-leukotrienes + systemic corticosteroids in high doses + long acting beta 2 agonists + long acting theophylline). The results don't match the classical description of WS, with a dominance of severe forms.

Conclusions: in general medical practice WS has a frequency of 8.66% among asthmatic population, and the mild and moderate forms represent 53.65% and it seems they keep like that a long time.

Publication types

  • English Abstract
  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Aspirin / adverse effects*
  • Asthma / chemically induced
  • Asthma / diagnosis
  • Asthma / epidemiology*
  • Chronic Disease
  • Drug Hypersensitivity / complications*
  • Female
  • Humans
  • Immunoglobulin E / blood
  • Male
  • Medical Records
  • Middle Aged
  • Nasal Polyps / diagnosis
  • Nasal Polyps / epidemiology*
  • Prevalence
  • Prognosis
  • Rhinitis, Allergic, Perennial / epidemiology
  • Romania / epidemiology
  • Severity of Illness Index
  • Spirometry
  • Syndrome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunoglobulin E
  • Aspirin